9
Views
0
CrossRef citations to date
0
Altmetric
Review

Update on the use of osteoarthritis-specific outcome measures

&
Pages 337-346 | Published online: 09 Jan 2014

References

  • McAlindon TE, Cooper C, Kirwan JR, Dieppe PA. Knee pain and disability in the community. Br. Rheumatol 31,189–192 (1992).
  • Long M. The family Encyclopaedia of Medicine and Health. Robinson, London, UK (2000).
  • Pendleton A, Arden N, Dougados M et al. EULAR recommendations for the management of knee osteoarthritis: report of a task force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT). Ann. Rheumatic Diseases 59(12), 936–944 (2000).
  • American College of Rheumatological Subcommittee On Osteoarthritis Guidelines. Recommendations for the medical management of osteoarthritis of the hip and knee. Arthritis & Rheumatism 43(9), 1905–1915 (2000).
  • Altman RD. The syndrome of osteoarthritis. j Rheumatology24, 766–767 (1997).
  • •Brief review of the etiology and epidemiology of OA.
  • Felson DT, Lawrence RC, Dieppe PA. Osteoarthritis: New Insights: Part 1: The disease and its risk factors. Ann. Intern. Med. 133(8), 635–646 (2000).
  • Oliveira SA, Felson DT, Reed JI, Cirillo PA, Walker AM. Incidence of symptomatic hand, hip and knee osteoarthritis among patients in a health maintenance organisation. Am. Coll Rheumatol 38(8), 1134–1141 (1995).
  • Brazier JE, Harper R, Munro JF, Walters SJ Snaith ML. Generic and condition-specific outcome measures for people with osteoarthritis of the knee. Rheumatology38, 870–877 (1999).
  • Bellamy N. Outcome measurement in osteoarthritis clinical trials. j Rheumatology 24 (Suppl. 43), 49–51 (1995).
  • Brooks P, Boers M Tugwell P. Introduction: OMERACT 111-The "ACT" Revisited. Rheumatology24, 764–765 (1997).
  • Bellamy N, Kirwan J, Boers M etal. Recommendations for a core set of outcome measures for future Phase III clinical trials in knee, hip and hand osteoarthritis. consensus development at OMERACT 111.1 Rheumatology24,799–802 (1997).
  • ••Key paper with recommendations of whatoutcome measures to use in OA studies.
  • Bellamy N. Osteoarthritis clinical trials: candidate variables and clinimetric properties. Rheumatology24, 768–778 (1997).
  • ••Excellent review of OA outcomemeasures.
  • Ravaud P, Dougados M. Radiographic assessment in osteoarthritis. Rheumatology 24, 786–791 (1997).
  • Patrick DL, Bergner M. Measurement of health status in the 1990s. Ann. Rev Public Health 11,165–183 (1990).
  • Guyatt GH, Feeny DH, Patrick DL. Measuring health-related quality of life. Ann. Intern. Med. 118(8), 622–629 (1993).
  • Liang MH, Fossel AH, Larson MG. Comparisons of five health status instruments for orthopaedic evaluation. Med. Care 28(7), 632–642 (1990).
  • Bombardier C, Melfi CA, Paul J et al. Comparison of a generic and a disease specific measure of pain and physical function after knee replacement surgery. Med. Care 33(Suppl.), A5131-144 (1995).
  • Bellamy N, Buchanan WW Goldsmith CH et al Validation study of WOMAC: A health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee.j Rheumatology15,1833–1840 (1988).
  • •Initial paper on WOMAC, one of the recommended outcome measures for OA studies.
  • Bachmeier CJM, March LM, Cross MJ et al A comparison of outcomes in osteoarthritis patients undergoing total hip and knee replacement surgery. Osteoarthritis & Cartilage 9,137–146 (2001).
  • Ehrich EW, Davies GM, Watson DJ, Bolognese JA, Seidenberg BC, Bellamy N. Minimal perceptible clinical improvement with the WOMAC osteoarthritis index questionnaires and global assessments in patients with Osteoarthritis. Rheumatology27(11), 2635–2641 (2000).
  • Roos EM, Roos HP, Lohmander LS, Ekdahl C, Beynnon BD. Knee Injury and Osteoarthritis Outcome Score (KOOS) - Development of a self-administered outcome measure. J. Orthopaedic Sports Physical Ther. 28(2), 88–96 (1998).
  • Englund M, Roos EM, Roos HP, Lohmander LS. Patient-relevant outcomes fourteen years after meniscectomy: influence of type of meniscal tear and size of resection. Rheumatology 40(6), 631–639 (2001).
  • Lequesne MG, Mery C, Samson M, Gerard P Indexes of severity for osteoarthritis of the hip and knee: Validation — Value in comparison with other assessment tests. Land. j Rheumatol. (Suppl. 65), 85–89 (1987).
  • Lequesne MG. The algofunctional indices for hip and knee osteoarthritis. Rheumatology24, 779–781 (1997).
  • Gentelle-Bonnassies S, Le-Claire P, Mezieres M, Ayral X, Dougados M. Comparison of the responsiveness of symptomatic outcome measures in knee osteoarthritis. Arthritis Care Res. 13 (5), 280–285 (2000).
  • Dreiser R-L, Maheu E, Guillou JB et al Validation of an algofunctional index for osteoarthritis of the hand. Rev Rhumatisme English ed 6\(Suppl. 1), 43S-53S (1995).
  • Drieser RL, Maheu E, Guillou GB. Sensitivity to change of the functional index for hand osteoarthritis. Osteoarthritis & Cartilage 8(Suppl. A), S25—S28 (2000).
  • Maheu E, Drieser RL, Guillou GB, Dewailly J. Hand osteoarthritis patients characteristics according to the existence of a hormone replacement therapy. Osteoarthritis & Cartilage 8(Suppl. A), S33—S37 (2000).
  • Dreiser RL, Gersberg M, Thomas F, Courcier S. Ibuprofen 800mg for the treatment of osteoarthritis of the interphalangeal joints of the hand or trapezo metacarpal joint. Rev Rhum. Engl Ed. 60(11), 719–724 (1993).
  • Graber-Duvernay B, Forestier R, Francon A. Efficacy of the Berthollet technique at Aix les Bains spa on functional impairment in hand osteoarthritis. A controlled therapeutic study. Rhumatologie 49(4), 151–156 (1997).
  • Jones G, Cooley HM, Bellamy N. A cross- sectional study of the association between Heberden's nodes, radiographic osteoarthritis of the hands, grip strength, disability and pain. Osteoarthritis & Cartilage 9(7), 606–611 (2001).
  • Poirandeau S, Chevalier X, Conrozier T etal. Reliability, validity, and sensitivity to change of the Cochin hand functional disability scale in hand osteoarthritis. Osteoarthritis & Cartilage 9 (6), 570–577 (2001).
  • Fries JF, Spitz PW, Kraines RG, Holman HR. Measurement of patient outcome in arthritis. Arthritis & Rheum. 23,137–145 (1980).
  • Griffiths G, Bellamy N, Bailey WH et al A comparative study of the relative efficiency of the WOMAC, AIMS and HAQ instruments in evaluating the outcome of total knee arthroplasty. Inflammopharmacology3, 1–6 (1995).
  • Meenan RF, Gertman PM, Mason JH. Measuring health status in arthritis: The Arthritis Impact Measurement Scales. Arthritis Rheum. 23,146–152 (1980).
  • Meenan RF, Mason JH, Anderson JJ etal. The content and properties of a revised and expanded Arthritis Impact Measurement Scales Health Status Questionnaire. Arthritis Rheum. 35, 1–10 (1992).
  • Bowling A. Measuring Disease: A review of Disease-specific quality of life measurement scales. Open University Press, Buckingham, UK (1995).
  • ••Comprehensive description and summaries of various outcome measures.
  • Poiraudeau S, Dougados M, Ait-Hadad H etal. Evaluation of the French version of a quality of life scale (AIM52) in Rheumatology patients? Rev Rhum. Engl. Ed. 60(9), 466–472 (1993).
  • Listrat V, Ayral X, Patamello F, Bonvarlet JP, Simonnet J, Dougados M. Arthroscopic evaluation of potential structure modifying activity of hyaluronan in osteoarthritis of the knee. Osteoarthritis & Cartilage 5(3), 153–160 (1997).
  • Jette AM, Deniston OL. Inter-observer reliability of a functional status assessment instrument. J. Chronic Diseases 31,573–580 (1978).
  • Jette AM, Davies AR, Cleary PD etal The Functional Status Questionnaire: Reliability and validity when used in primary care. .1. Gen Intern Med. 1,143-149 (1986).
  • Deniston OL, Jette AM. A functional status assessment instrument: validation in an elderly population. Health Services Res 15, 21–34 (1980).
  • Lo IKY, Griffin S, Kirldey A. The development of a disease-specific quality of life measurement tool for osteoarthritis of the shoulder: The Western Ontario Osteoarthritis of the Shoulder (WOOS) index. Osteoarthritis & Cartilage 9(8), 771–778 (2001).
  • Domsic RT, Saltzman CL. Ankle osteoarthritis scale. Foot Ankle Int. 19(7), 466–471 (1998).
  • Bowling A. Measuring Health: A review of quality of life measurement scales, 2nd edition. Open University Press, Buckingham, UK (1997).
  • ••Book with comprehensive description andsummary of generic outcome measures.
  • Ware JE Jr, Snow KK, Kosinski M, Gandek B. SF-36 Health Survey Manual and Interpretation Guide. The Health Institute, New England Medical Centre, Boston MA, USA (1993).
  • Ware JE Jr, Kosinski M, Keller SD. SF-36 Physical and Mental Health Summary Scales: A User's Manual Health Institute, Boston, USA (1994).
  • Kosinski M, Keller SD, Hatoum HT, Kong SX, Ware JE Jr. The SF-36 Health Survey as a Generic Outcome Measure in Clinical Trials of Patients With Osteoarthritis and Rheumatoid Arthritis: Tests of Data Quality, Scaling Assumptions and Score Reliability. Med. Care 37(5 Suppl.), MS10—MS22 (1999).
  • Kosinski M, Keller SD, Ware JE Jr, Hatoum HT, Kong SX. The SF-36 health survey as a generic outcome measure in clinical trials of patients with osteoarthritis and rheumatoid arthritis: relative validity of the scales in relation to clinical measures of arthritis severity. Med Care 37(5 Suppl.), M523—M539 (1999).
  • Gandhi SK, Salmon JW, Zhao SZ, Lambert BL, Gore PR, Conrad K. Psychometric evaluation of the 12-item short-form health survey (SF-12) in osteoarthritis and rheumatoid arthritis clinical trials. Clin. Therapeut. 23(7), 1080–1098 (2001).
  • Ware JE Jr, Keller SD, Hatoum HT, Kong SX. The SF-36 Arthritis-Specific Health Index (ASHI): I Development and cross-validation of scoring algorithms. Med. Care 37(5 Suppl.), M540—M550 (1999).
  • Keller SD, Ware JE Jr., Hatoum HT, Kong SX. The SF-36 arthritis-specific health index (ASHI): II test of validity in four clinical trials. Med Care 37(5 Suppl.), M551—M560 (1999).
  • Fagnani F, Bouvenot G, Valat JP eta] Medico-economic analysis of diacerein with or without standard therapy in the treatment of osteoarthritis. PharmacoEconomics13(1 pt 2), 135–146 (1998).
  • The EuroQol Group. EuroQol - a facility for the measurement of health-related quality of life. kkalth Polig,16,199–207 (1990).
  • Williams A. The Measurement and Valuation of Health: A Chronicle. Discussion Paper 136, Centre for Health Economics, University of York, UK (1995).
  • Torrance GW, Boyle MET, Horwood SR Applications of multi-attribute utility theory to measure social preferences for health states. Operat. Res. 30,1043–1069 (1982).
  • Torrance GW, Furlong W Feeny D, Boyle M. Multi-attribute preference functions: Health Utilities Index. PharmacoEconomics 7,503–520(1995).
  • Feeny D, Furlong W, Boyle M, Torrance GW Multi-attribute health status classification systems: Health Utilities Index. PharmacoEconomics7, 490–502 (1995).
  • Bennett KJ, Torrance GW, Moran LA, Smith F, Goldsmith CH. Health state utilities in knee replacement surgery: the development and evaluation of the McKnee. j Rheumatology 24 (9), 1796–1805 (1997).
  • Brazier J, Usherwood T, Harper R, Thomas K. Deriving a Preference-based Single Index from the UK SF-36 Health Survey. J. Clin. Epidemiol 51 (11), 1115–1128 (1998).
  • Brazier J, Roberts J, Deverill M. The estimation of a preference-based measure of health from the SF-36.J Health Econ. 21, 271–292 (2002).
  • •Useful paper which shows how existing generic HRQOL instruments can be adapted to produce a preference-based measure.
  • Brazier J, Deverill M, Green C, Harper R, Booth A. A review of the use of health status measures in economic evaluation. Health Technol. Assess. 3(9), 1–164 (1999).
  • •Review paper.
  • Davies GM, Watson DJ, Bellamy N. Comparison of the responsiveness and the relative effect size of the WOMAC and the SF-36 in a randomised, clinical trial of osteoarthritis patients. Arthritis Cam Res. 12(3), 172–179 (1999).
  • Hochberg MC, Altman RD, Brandt KD, Moskowitz RW. Design and conduct of clinical trials in osteoarthritis: preliminary recommendations from a task force of the osteoarthritis research society. I Rheumatology 24,792–794 (1997).
  • ••Useful paper on the design of clinical trialsin OA.
  • Bellamy N, Campbell J, Stevens J, Pilch L, Stewart C, Mahmod Z. Validation study of a computerised version of the WOMAC. I Rheumatology 24(12), 2413–2415 (1997).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.